Last reviewed · How we verify
NCT07423039: ROSA
Auricular Acupressure for Perioperative Anxiety and Pain in Therapeutic Breast Surgery (ROSA)
NA trial testing Auricular Acupressure NADA in Breast Cancer Females in 66 participants. Not yet recruiting.
30 June 2027
Quick facts
| Lead sponsor | Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 66 |
| Start date | 1 February 2026 |
| Primary completion | 30 June 2027 |
| Estimated completion | 31 December 2027 |
Drugs / interventions tested
- Auricular Acupressure NADA
Conditions studied
- Breast Cancer Females — all drugs for Breast Cancer Females →
Sponsor
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) — full company profile →
Who can join
Adults 18 to 99, female only, with Breast Cancer Females. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This randomized, controlled, single-center trial investigates the effects of auricular acupressure, administered according to the National Acupuncture Detoxification Association (NADA) protocol, on perioperative anxiety and pain in patients with a first diagnosis of breast cancer undergoing therapeutic breast surgery. Participants receiving auricular acupressure according to the NADA protocol will be compared with patients receiving standard care alone.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07423039
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Breast Cancer Females
Currently open trials in the same condition.
- NCT07256769 — Vitamin k, D-chiro Inositol and α-lactalbumin in Bone Homeostasis · recruiting
- NCT07162675 — Step Count and Treatment Response in Neoadjuvant Breast Cancer · recruiting
- NCT06781762 — Short-term Impacts of Endocrine Therapy on Cardiovascular and Brain Health Outcomes in Breast Cancer · recruiting
- NCT07553702 — Dance Intervention in Breast Cancer Treatment · NA · active not recruiting
- NCT06852833 — One-day Mind Programme for Women With Breast Cancer · NA · active not recruiting
Other Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) trials
Trials by the same sponsor.
- NCT06931132 — Cancer-related Fatigue and Symptom Clusters - Effects of Virtual, Imagined and Real-life Nature-based Therapy in Cancer · NA · enrolling by invitation
- NCT03931928 — Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients · Phase 2 · completed
- NCT03769220 — Evaluation of the Measurement Properties of a 5 Time Repeated Instrumented Timed Up and Go (5iTUG) · completed
- NCT03100201 — Robotic-assisted Training After Upper Arm Fracture · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07423039 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)
- Last refreshed: 20 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07423039.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing